Foundation Medicine Inc (FMI) financial statements (2022 and earlier)

Company profile

Business Address 150 SECOND STREET
CAMBRIDGE, MA 02141
State of Incorp. DE
Fiscal Year End December 31
SIC 8071 - Medical Laboratories (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
12/31/2016
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments53,41860,29371,40476,81471,51799,051143,019
Cash and cash equivalents53,41860,29371,40476,81436,53249,07563,617
Short-term investments    34,98549,97679,402
Receivables52,34141,32130,12615,49617,72710,72810,213
Inventory, net of allowances, customer advances and progress billings25,81516,41113,17110,4008,92210,34910,438
Inventory25,81516,41113,17110,4008,92210,34910,438
Contract with customer, asset200 
Other undisclosed current assets5,44113,0039,1184,6125,1025,3385,251
Total current assets:137,215131,028123,819107,322103,268125,466168,921
Noncurrent Assets
Property, plant and equipment50,77841,60741,11939,13638,71339,55341,486
Restricted cash and investments 2,3052,3052,3052,3051,3951,395
Other noncurrent assets3,1422,2251,7601,7962,0802,1402,233
Other undisclosed noncurrent assets2,305      
Total noncurrent assets:56,22546,13745,18443,23743,09843,08845,114
TOTAL ASSETS:193,440177,165169,003150,559146,366168,554214,035
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities61,09048,25858,67144,42440,44429,66732,476
Accounts payable28,83425,86521,92616,17815,17510,42711,898
Accrued liabilities32,25622,39336,74528,24625,26919,24020,578
Deferred rent credit1,854 
Deferred revenue and credits4,7034,0303,1413,3104,4034,428
Other undisclosed current liabilities18,9104,8013,7422963,7422933,747
Total current liabilities:81,85457,76266,44347,86147,49634,36340,651
Noncurrent Liabilities
Liabilities, other than long-term debt110,00090,00060,00030,000   
Due to related parties110,00090,00060,00030,000   
Total noncurrent liabilities:110,00090,00060,00030,000   
Total liabilities:191,854147,762126,44377,86147,49634,36340,651
Stockholders' equity
Stockholders' equity attributable to parent(8,536)18,89631,66863,43789,516126,317164,846
Common stock4444444
Additional paid in capital550,511544,541537,904531,593525,041517,698509,664
Accumulated other comprehensive income (loss)(200)(177)1097865(49)(14)
Accumulated deficit(558,851)(525,472)(506,349)(468,238)(435,594)(391,336)(344,808)
Total stockholders' equity:(8,536)18,89631,66863,43789,516126,317164,846
Other undisclosed liabilities and equity10,12210,50710,8929,2619,3547,8748,538
TOTAL LIABILITIES AND EQUITY:193,440177,165169,003150,559146,366168,554214,035

Income statement (P&L) ($ in thousands)

6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
12/31/2016
Q4
Revenues57,00652,84048,91342,65835,00426,32828,824
Revenue, net   26,32828,824
Cost of revenue(22,126)(21,862)(21,533)(14,462)(17,207)(17,117)(16,737)
Gross profit:34,88030,97827,38028,19617,7979,21112,087
Operating expenses(66,964)(67,399)(64,896)(60,622)(62,111)(54,998)(47,072)
Other undisclosed operating loss     (900)(720)
Operating loss:(32,084)(36,421)(37,516)(32,426)(44,314)(46,687)(35,705)
Nonoperating income182  60 14496
Other nonoperating income182  60 144 
Interest and debt expense  1    
Other undisclosed income from continuing operations before equity method investments, income taxes      57
Net loss:(31,902)(36,421)(37,515)(32,366)(44,314)(46,543)(35,552)
Other undisclosed net income (loss) attributable to parent(1,477)(994)(596)(278)5690(57)
Net loss available to common stockholders, diluted:(33,379)(37,415)(38,111)(32,644)(44,258)(46,453)(35,609)

Comprehensive Income ($ in thousands)

6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
12/31/2016
Q4
Net loss:(31,902)(36,421)(37,515)(32,366)(44,314)(46,543)(35,552)
Other comprehensive income (loss)(23)(286)3113114(35)(48)
Comprehensive loss:(31,925)(36,707)(37,484)(32,353)(44,200)(46,578)(35,600)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(1,477)(994)(596)(278)5690(57)
Comprehensive loss, net of tax, attributable to parent:(33,402)(37,701)(38,080)(32,631)(44,144)(46,488)(35,657)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: